In-Depth Androgenetic Alopecia Treatment Market Report: Business Trends, Growth Factors, and Forecast to 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Latest Market Insights for the Androgenetic Alopecia Treatment Industry?
There has been a robust expansion in the market size of Androgenetic Alopecia treatment in the recent past. The projections indicate an increase from $2.29 billion in 2024 to $2.44 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. The noteworthy growth in the historical phase can be linked to a focus on enhancing patient outcomes and their quality of life. It is also driven by a rise in the elderly population and increment in healthcare spending.
The market for androgenetic alopecia treatment is anticipated to witness considerable growth in the coming years. It is projected to reach “$3.19 billion by 2029, with a compound annual growth rate (CAGR) of 6.9%. The projected growth during the forecast period can be credited to an increased occurrence of hair loss, the widespread of chronic diseases like cancer, polycystic ovary syndrome (PCOS), and rheumatoid arthritis, alongside the demand for effective hair loss solutions. The forecast period is expected to showcase significant trends like collaborations, product approvals, investments, and research and development activities.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15721&type=smp
What Forces Are Driving The Growth Of The Androgenetic Alopecia Treatment Industry?
The upward trajectory of hair loss instances is predicted to boost the progression of the androgenetic alopecia treatment market in the future. Alopecia or hair loss involves the reduction or total absence of hair on the scalp or other parts of the body. Instances of hair loss can be traced back to things like nutritional lack, hormonal shifts, genetic factors, and elevated stress levels. The approach to treating androgenetic alopecia ranges from hormonal control, follicle provocation, to surgical restoration, all geared towards managing hair loss and encouraging hair regrowth. For example, a piece by the Hair Society, a comprehensive professional organization in the US, stated in March 2022 that approximately 21 million women and 35 million men worldwide were affected by hair loss. Furthermore, roughly 8 million women and 6.5 million men in the UK are going through hair loss, as per the data from the National Health Service, a government agency in the UK, in 2024. Alongside this, over 650,000 hair transplant procedures are performed annually. Thus, the escalation in hair loss cases propels the growth of the androgenetic alopecia treatment market.
The androgenetic alopecia treatment market covered in this report is segmented –
1) By Treatment Type: Pharmaceutical, Device
2) By Medication Type: Prescription, Over-The-Counter
3) By Gender: Male, Female
4) By End-User: Homecare Settings, Dermatology, Clinics, Other End-Users
Subsegments:
1) By Pharmaceutical: Oral Medications ( Finasteride), Topical Medications (Minoxidil), Hormonal Therapy
2) By Device: Laser Therapy Devices, Hair Transplant Devices, Scalp Micropigmentation Devices
What Trends Are Currently Influencing Growth In The Androgenetic Alopecia Treatment Market?
Key players in the androgenetic alopecia treatment market are evolving new drug options to address hair loss through various methods such as fostering hair follicle regeneration, suppression of hair loss causing hormones, and implementing unique delivery methods like topical solutions and oral drugs. For example, Pfizer Inc., an American healthcare corporation, announced in June 2023, it received approval from FDA for their product LITFULO (ritlecitinib) – a daily oral treatment for people aged 12 and above suffering from severe alopecia areata. LITFULO is a kinase inhibitor that deactivates Janus kinase 3 (JAK3) and the tyrosine kinase found in the hepatocellular carcinoma (TEC) kinases. The basis for FDA approval was the results from the ALLEGRO Phase 2b/3 study where 23% of participants treated with LITFULO 50mg showed at least 80% scalp hair improvement after six months compared to 1.6% using a placebo. This product provides a fresh solution for those dealing with significant hair loss, tackling alopecia areata – an unmet requirement till now.
Who Are The Primary Players Operating Across The Global Androgenetic Alopecia Treatment Market?
Major companies operating in the androgenetic alopecia treatment market are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Eli Lilly and Company, Daiichi-Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd., Allergan Plc, Aurobindo Pharma Limited, Dr Reddy’s Laboratories Ltd., Cipla Limited, Fagron Inc., Vitabiotics Ltd., Cosmo Pharmaceuticals NV, Aclaris Therapeutics Inc., Curallux LLC, PureTech Health, Technoderma Medicines Inc., Theradome Inc., Lexington International, HCell Inc., Follica Inc., Ranbaxy Laboratories Ltd., Apira Science Inc., Freedom Laser Therapy Inc., Histogen Inc.
Which Region Offers The Most Growth Potential For The Androgenetic Alopecia Treatment Market Through 2029?
North America was the largest region in the androgenetic alopecia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the androgenetic alopecia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15721&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
